SecBot SecBot
6-K ·Filed May 28, 2026

RDY

DR REDDYS LABORATORIES LTD
NEUTRAL
Impact 2/10
Horizondays Processed5mo ago SEC0001575872-26-000370
Notable filing: 6-K
Actionable Insight • Neutral

Routine compliance filing with no trading implications. Monitor upcoming quarterly results for fundamental business performance indicators.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$13.52
T+0 close · May 28, 2026 · via day close
Latest settled
−9.91%
T+60 · $12.18
Vs SPY
−11.65%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 28 $13.52entry
  2. T+1 · 6mo ago +0.81%α +0.57% · $13.63
  3. T+5 · 6mo ago −3.70%α −3.65% · $13.02
  4. T+20 · 5mo ago +13.76%α +16.90% · $15.38
  5. T+60 · 3mo ago −9.91%α −11.65% · $12.18
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Dr. Reddy's filed its annual Secretarial Compliance Report for FY ended March 31, 2026, certifying compliance with SEBI listing regulations, insider trading rules, and corporate governance standards. The report confirms no material non-compliances, no regulatory actions taken against the company, and no resignation of statutory auditors during the period.

Key Facts

  • Annual Secretarial Compliance Report for FY ended March 31, 2026 filed on May 28, 2026
  • No non-compliances reported across all SEBI regulations examined
  • No actions taken by SEBI or stock exchanges against the company, promoters, directors, or subsidiaries
  • No resignation of statutory auditors from the listed entity or material subsidiaries during the review period
  • All applicable policies under SEBI regulations adopted and timely updated
  • Board performance evaluation conducted as prescribed
  • Related party transactions received prior Audit Committee approval

Financial Impact

No financial magnitude, this is a governance compliance certification with no monetary impact

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
50% bullish (44 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001575872-26-000370
Document: 0001575872-26-000370-index.html0001575872-26-000370
Document: 0001575872-26-000370.txt0001575872-26-000370

Track record

73 reports on RDY

Performance horizon

7 of 12 bullish or bearish reports moved the stock their way by T+5. Best: +23.28% at T+20 after the Jun 26, 2026 report. 7 of 12 went positive at some point.

Filters
  1. Nov 16, 2026today 6-K Bullish 4/10 Entry $14.85 Now $14.70 −1.01% settles Nov 23
  2. Nov 10, 20266d ago 6-K Neutral 2/10 Entry $14.86 Now $14.70 −1.08% settles Nov 17
  3. Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $15.05 to $14.70 Now $14.70 −2.33% ▼ −2.33% −0.63% vs SPY
  4. Nov 5, 202611d ago 6-K Neutral 4/10 Entry $14.53 to $14.73 Now $14.70 +1.17% ▲ +1.38% −1.91% vs SPY
  5. Nov 4, 202612d ago 6-K Neutral 2/10 Entry $14.77 to $14.84 Now $14.70 −0.47% ▲ +0.47% +1.39% vs SPY
  6. Nov 2, 202614d ago 144 Bearish 5/10 Entry $14.13 to $15.05 Now $14.70 −4.03% ▼ −6.51% −6.43% vs SPY
  7. Oct 29, 202618d ago 6-K Neutral 2/10 Entry $14.11 to $14.53 Now $14.70 +4.18% ▲ +2.98% +7.70% vs SPY
  8. Oct 28, 202619d ago 6-K Neutral 3/10 Entry $14.11 to $14.53 Now $14.70 +4.18% ▲ +2.98% +7.70% vs SPY
  9. Oct 26, 202621d ago 6-K Neutral 2/10 Entry $13.75 to $14.17 Now $14.70 +6.91% ▲ +3.05% +4.32% vs SPY
  10. Oct 26, 202621d ago 6-K Neutral 2/10 Entry $13.75 to $14.17 Now $14.70 +6.91% ▲ +3.05% +4.32% vs SPY
Showing 10 of 73

US Market Status

Market Closed · Opens in 5h 7m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 28, 2026